CFG
ABCL icon

Citizens Financial Group’s AbCellera Biologics ABCL Stock Holding History

Citizens Financial Group’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$914K Hold
261,890
– – 0.01% 412
2025
Q4 		$896K Hold
261,890
– – 0.01% 421
2025
Q3 		$1.32M Buy
+261,890
New +$1.15M 0.02% 345
2024
Q4 		– Sell
-311,890
Closed -$811K – 579
2024
Q3 		$811K Hold
311,890
– – 0.02% 324
2024
Q2 		$923K Buy
+311,890
New +$1.18M 0.02% 280

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citizens Financial Group's ABCL Position: Q1 2026 in Review

Citizens Financial Group held its AbCellera Biologics (ABCL) position steady in Q1 2026 at 261,890 shares worth $914K. The position accounts for 0.01% of the portfolio, ranked #412.

Citizens Financial Group first reported a position in ABCL in Q2 2024 and has held it in 5 quarters since. The position peaked at $1.32M in Q3 2025. 138 funds tracked by Wall St. Rank hold ABCL as of Q1 2026.

  • Citizens Financial Group held 261,890 shares of AbCellera Biologics worth $914K as of Q1 2026.
  • Citizens Financial Group left its AbCellera Biologics share count unchanged in Q1 2026.
  • AbCellera Biologics made up 0.01% of Citizens Financial Group's portfolio in Q1 2026, its #412 holding.
  • Citizens Financial Group first reported a position in AbCellera Biologics in Q2 2024 and has held it in 5 quarters since.
  • Citizens Financial Group's AbCellera Biologics position peaked at $1.32M in Q3 2025.
  • 138 funds tracked by Wall St. Rank held AbCellera Biologics as of Q1 2026.

Based on Citizens Financial Group's 13F filing for Q1 2026, filed 1 May 2026.